A. Sanders
Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 179 239 $ as of 2024-03-30
Profile
A.
Machelle Sanders is currently an Independent Director at BioCryst Pharmaceuticals, Inc., a Director at Fortrea Holdings, Inc., and the Secretary at The North Carolina Department of Commerce.
Previously, she served as an Independent Director at Radius Health, Inc., an Independent Director at NVN Liquidation, Inc., the Director at The North Carolina Biotechnology Center, a Director at NVN Liquidation, Inc., the Vice President-Manufacturing & General Manager at Biogen, Inc., and the Secretary at the North Carolina Department of Administration.
Ms. Sanders received her undergraduate degree from North Carolina State University and her graduate degree from Pfeiffer University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-06-16 | 27,742 ( 0.01% ) | 179 213 $ | 2024-05-30 | |
NVN LIQUIDATION INC
0.09% | 2023-06-26 | 25,248 ( 0.09% ) | 25 $ | 2024-03-30 |
FORTREA HOLDINGS INC.
-.--% | 2024-05-13 | 0 ( -.--% ) | - $ | 2024-05-30 |
A. Sanders active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 2022-02-07 |
| FORTREA HOLDINGS INC. | Director/Board Member | 2024-05-13 |
| The North Carolina Department of Commerce | Corporate Secretary | 2021-01-31 |
Former positions of A. Sanders
| Companies | Position | End |
|---|---|---|
| NVN LIQUIDATION, INC. | Director/Board Member | 2024-03-31 |
| NVN LIQUIDATION, INC. | Director/Board Member | 2023-09-26 |
| RADIUS HEALTH, INC. | Director/Board Member | 2022-08-14 |
| North Carolina Department of Administration | Corporate Secretary | 2021-01-31 |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 2014-12-31 |
Training of A. Sanders
| North Carolina State University | Undergraduate Degree |
| Pfeiffer University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| NVN LIQUIDATION, INC. | Health Technology |
| FORTREA HOLDINGS INC. | Commercial Services |
| Private companies | 5 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
| The North Carolina Department of Commerce | Government |
| North Carolina Department of Administration | Government |
| Research Triangle Park |
- Stock Market
- Insiders
- A. Sanders
